Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes (Q36404504)

14 August 2017

Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes (English)

1 reference

14 August 2017

0 references

20

Henrik Zetterberg

1 reference

14 August 2017

Ross W Paterson

2

0 references

Ninon Burgos

Ninon Burgos

4

0 references

Anna Barnes

Anna Barnes

9

0 references

David M. Cash

David M Cash

12

0 references

Jason D. Warren

Jason D Warren

17

0 references

Martin Rossor

Martin N Rossor

18

0 references

Sebastien Ourselin

13

Sebastien Ourselin

1 reference

14 August 2017

15

Michael P Lunn

1 reference

14 August 2017

3

Marc Modat

1 reference

14 August 2017

Philip S J Weston

1

1 reference

14 August 2017

Manuel J Cardoso

5

1 reference

14 August 2017

Nadia Magdalinou

6

1 reference

14 August 2017

Manja Lehmann

7

1 reference

14 August 2017

John C Dickson

8

1 reference

14 August 2017

Jamshed B Bomanji

10

1 reference

14 August 2017

Irfan Kayani

11

1 reference

14 August 2017

Jamie Toombs

14

1 reference

14 August 2017

Catherine J Mummery

16

1 reference

14 August 2017

Nick C Fox

19

1 reference

14 August 2017

Jonathan M Schott

21

1 reference

14 August 2017

2 November 2015

1 reference

Alzheimer's & dementia (Amsterdam, Netherlands)

14 August 2017

1 reference

14 August 2017

1

1 reference

14 August 2017

4

1 reference

14 August 2017

440-446

1 reference

Dissecting IWG-2 typical and atypical Alzheimer's disease: insights from cerebrospinal fluid analysis

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Multi-contrast attenuation map synthesis for PET/MR scanners: assessment on FDG and Florbetapir PET tracers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Florbetapir positron emission tomography and cerebrospinal fluid biomarkers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

CSF biomarker variability in the Alzheimer's Association quality control program

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challenges

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Primary progressive aphasia: defining genetic and pathological subtypes.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

CSF markers for incipient Alzheimer's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Concordance between cerebrospinal fluid biomarkers and [11C]PIB PET in a memory clinic cohort

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Validation of the Addenbrooke's Cognitive Examination III in frontotemporal dementia and Alzheimer's disease

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Cerebrospinal fluid Aβ1-40 improves differential dementia diagnosis in patients with intermediate P-tau181P levels

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1-42.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Posterior cortical atrophy

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4691234

Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects

21 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26835507

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Geodesic information flows

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26835507

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.DADM.2015.10.001

0 references

1 reference

14 August 2017

PubMed publication ID

26835507

1 reference